| Title |
A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders
|
|---|---|
| Published in |
BMC Psychiatry, July 2013
|
| DOI | 10.1186/1471-244x-13-196 |
| Pubmed ID | |
| Authors |
Ahmad Ghanizadeh, Ebrahim Moghimi-Sarani |
| Abstract |
This study examined the efficacy and safety of N-acetylcysteine (NAC) augmentation for treating irritability in children and adolescents with autism spectrum disorders (ASD). |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 2 | 25% |
| Venezuela, Bolivarian Republic of | 1 | 13% |
| Unknown | 5 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 13% |
| Science communicators (journalists, bloggers, editors) | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 229 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Sweden | 1 | <1% |
| France | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 224 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 40 | 17% |
| Student > Bachelor | 35 | 15% |
| Student > Master | 27 | 12% |
| Student > Ph. D. Student | 24 | 10% |
| Other | 21 | 9% |
| Other | 46 | 20% |
| Unknown | 36 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 78 | 34% |
| Psychology | 25 | 11% |
| Nursing and Health Professions | 23 | 10% |
| Neuroscience | 15 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 7% |
| Other | 38 | 17% |
| Unknown | 35 | 15% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 March 2021.
All research outputs
#1,582,755
of 25,654,806 outputs
Outputs from BMC Psychiatry
#518
of 5,502 outputs
Outputs of similar age
#13,219
of 210,582 outputs
Outputs of similar age from BMC Psychiatry
#7
of 53 outputs
Altmetric has tracked 25,654,806 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,502 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,582 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.